No immediate trading implications; monitor for any future strategic shifts or commentary from the new director, but this is a standard board expansion with an experienced medical device executive.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 6 $24.22entry
- T+1 · 8mo ago +4.29%α +3.45% · $25.26
- T+5 · 8mo ago +12.01%α +13.54% · $27.13
- T+20 · 8mo ago −1.82%α +0.23% · $23.78
- T+60 · 6mo ago +15.03%α +2.25% · $27.86
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Procept BioRobotics appointed Daniel Puckett to its board of directors and audit committee, effective March 5, 2026. Puckett, a former CFO of Shockwave Medical, brings medical device industry experience but the move is a routine governance update with no immediate financial impact.
Key Facts
- Daniel Puckett appointed to board of directors and audit committee effective March 5, 2026
- Board size increased from eight to nine members
- Puckett classified as Class III director with term expiring at 2027 annual meeting
- Puckett is independent and previously served as CFO of Shockwave Medical until February 2024
- No departures or executive changes announced
Financial Impact
Minimal to none
Risk Factors
- None identified from this filing
- Integration of new director may take time to influence strategy
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001588978-26-000013 |
| Document: 0001588978-26-000013-index-headers.html | 0001588978-26-000013 |
| Document: 0001588978-26-000013-index.html | 0001588978-26-000013 |
| Document: 0001588978-26-000013.txt | 0001588978-26-000013 |
Track record
16 reports on PRCT
4 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +22.73% at T+60 after the Feb 26, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 6, 202610d ago 144 Neutral 2/10 Entry $20.62 Now $23.54 +14.16% settles Feb 4
- Nov 4, 202612d ago 8-K Neutral 5/10 Entry $20.27 Now $23.54 +16.13% settles Feb 3
- Oct 30, 202617d ago SC 13G/A Neutral 2/10 Entry $19.20 Now $23.54 +22.60% settles Jan 28
- Oct 2, 20266w ago 8-K Neutral 2/10 Entry $17.82 Now $23.54 +32.10% settles Dec 30
- Sep 24, 20267w ago 8-K Neutral 3/10 Entry $17.20 Now $23.54 +36.86% settles Dec 21
- Aug 10, 202614w ago Insider Buy Bullish 5/10 Entry $21.71 to $19.98 Now $23.54 +8.43% ▼ −7.99% −6.09% vs SPY
- Jun 11, 202622w ago Institutional Cluster Mixed 4/10 Entry $27.69 to $21.35 Now $23.54 −14.99% ▼ −22.90% −26.72% vs SPY
- Jun 10, 202622w ago Insider Cluster Neutral 2/10 Entry $27.69 to $21.35 Now $23.54 −14.99% ▼ −22.90% −26.72% vs SPY
- Jun 10, 202622w ago Insider Cluster Neutral 2/10 Entry $27.69 to $21.35 Now $23.54 −14.99% ▼ −22.90% −26.72% vs SPY
- Jun 10, 202622w ago Insider Cluster Neutral 2/10 Entry $27.69 to $21.35 Now $23.54 −14.99% ▼ −22.90% −26.72% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers